237 related articles for article (PubMed ID: 32546168)
1. Combining texture features of whole slide images improves prognostic prediction of recurrence-free survival for cutaneous melanoma patients.
Peng Y; Chu Y; Chen Z; Zhou W; Wan S; Xiao Y; Zhang Y; Li J
World J Surg Oncol; 2020 Jun; 18(1):130. PubMed ID: 32546168
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.
Li G; Wang G; Guo Y; Li S; Zhang Y; Li J; Peng B
World J Surg Oncol; 2020 Sep; 18(1):249. PubMed ID: 32950055
[TBL] [Abstract][Full Text] [Related]
3. Recurrence risk stratification of hepatocellular carcinomas based on immune gene expression and features extracted from pathological images.
Ding T; Li X; Mo J; Alexander G; Li J
PLoS Comput Biol; 2023 Dec; 19(12):e1011716. PubMed ID: 38157378
[TBL] [Abstract][Full Text] [Related]
4. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
6. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma.
Fan Y; Liang X; Yu D
Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
Wu X; Chen S; Ji Q; Chen H; Chen X
Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
[TBL] [Abstract][Full Text] [Related]
8. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
9. A novel RNA sequencing-based prognostic nomogram to predict survival for patients with cutaneous melanoma: Clinical trial/experimental study.
Tian J; Yang Y; Li MY; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18868. PubMed ID: 32011509
[TBL] [Abstract][Full Text] [Related]
10. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
[TBL] [Abstract][Full Text] [Related]
11. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
Bedin V; Adam RL; de Sá BC; Landman G; Metze K
BMC Cancer; 2010 Jun; 10():260. PubMed ID: 20525386
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of autophagy-related-gene biomarker and nomogram for predicting the survival of cutaneous melanoma.
Wan Q; Jin L; Su Y; Liu Y; Li C; Wang Z
IUBMB Life; 2020 Jul; 72(7):1364-1378. PubMed ID: 32080971
[TBL] [Abstract][Full Text] [Related]
13. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients.
Greenhaw BN; Covington KR; Kurley SJ; Yeniay Y; Cao NA; Plasseraud KM; Cook RW; Hsueh EC; Gastman BR; Wei ML
J Am Acad Dermatol; 2020 Sep; 83(3):745-753. PubMed ID: 32229276
[TBL] [Abstract][Full Text] [Related]
14. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; MandalĂ M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract][Full Text] [Related]
16. A nine-gene signature predicting clinical outcome in cutaneous melanoma.
Brunner G; Reitz M; Heinecke A; Lippold A; Berking C; Suter L; Atzpodien J
J Cancer Res Clin Oncol; 2013 Feb; 139(2):249-58. PubMed ID: 23052696
[TBL] [Abstract][Full Text] [Related]
17. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha.
Tas F; Erturk K
Cancer Chemother Pharmacol; 2019 Sep; 84(3):521-526. PubMed ID: 30997532
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
[TBL] [Abstract][Full Text] [Related]
20. Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.
Yang CQ; Wang H; Liu Z; Hueman MT; Bhaskaran A; Henson DE; Sheng L; Chen D
PLoS One; 2021; 16(9):e0257949. PubMed ID: 34591891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]